Skip to content

The Study of Effectiveness of Mindfulness integrated Cognitive Behavior Therapy on Psychopathology indicators in females with breast cancer

The Study of Effectiveness of Mindfulness integrated Cognitive Behavior Therapy on Psychopathology indicators in females with breast cancer: Randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160103025817N6
Enrollment
30
Registered
2022-04-06
Start date
2022-02-20
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: depression. Condition 2: anxiety. Major depressive disorder, recurrent, moderate Anxiety disorder due to known physiological condition

Interventions

Intervention 1: Intervention group: Cognitive-behavioral therapy integrated with mindfulness is a regular therapeutic approach that integrates mindfulness meditation with the basic components of cogni

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Being in the age group of 30 to 60 years Ability to read and write and participate in treatment sessions More than 6 months have passed since the diagnosis of cancer Having informed consent to participate in research and completing the informed consent form Non-development of chronic physical diseases such as diabetes and thyroid disorders Do not attend psychotherapy sessions for six months before starting treatment Have no other cancers No problems with hearing and vision Non-abuse of drugs Non-development of severe mental illnesses including schizophrenia, bipolar type 1 disorders and severe personality disorders

Exclusion criteria

Exclusion criteria: Participate in psychotherapy sessions and other support groups at the same time as the research period

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: DASS Depression Inventory.;Anxiety. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: DASS Anxiety Inventory.;Stress. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: DASS Stress Inventory.;Sleep quality. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: Pittsburgh Sleep Quality Index.;Sexual function. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: Rosen Sexual Function Questionnaire.;Body image. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: Hopwood body image Questionnaire.;Demoralization. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: kissane demoralization Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. AA. parvizifard

Kermanshah University of Medical Sciences

Parvizia@yahoo.com+98 83 3427 4617

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 8, 2026